Targeting Type IV pili as an antivirulence strategy against invasive meningococcal disease.
Denis K, Le Bris M, Le Guennec L, Barnier JP, Faure C, Gouge A, Bouzinba-Ségard H, Jamet A, Euphrasie D, Durel B, Barois N, Pelissier P, Morand PC, Coureuil M, Lafont F, Join-Lambert O, Nassif X, Bourdoulous S.
Denis K, et al. Among authors: barnier jp.
Nat Microbiol. 2019 Jun;4(6):972-984. doi: 10.1038/s41564-019-0395-8. Epub 2019 Mar 25.
Nat Microbiol. 2019.
PMID: 30911127